Peer-reviewedCC BYFrontiers in pharmacology16 Oct 2026

Efficacy and safety of antibody-drug conjugates in pretreated HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials

Fen Liu¹
Yong Pan¹
Jinlan Li¹
Xiaojie Hu¹
Guisen Yin²

¹Department of Pharmacy, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University , , ,
²Department of Pharmacy, Yantai Hospital of Traditional Chinese Medicine , , ,

Efficacy and safety of antibody-drug conjugates in advanced small cell lung cancer: a systematic review and single-arm meta-analysis of prospective clinical trials
Translational cancer research28 Aug 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
Efficacy and safety of antibody–drug conjugates in EGFR-mutated non-small cell lung cancer after EGFR-TKI resistance: a systematic review and meta-analysis
Yilin Chen, Shuaixuan Chen, Hang Zhang +3
Frontiers in Oncology14 Oct 2026Peer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
Efficacy and safety of FXI antibody cenvacibart compared with aspirin for venous thromboprophylaxis in patients after total knee arthroplasty (ROXI-ASPEN): study protocol for a phase 3, double-blinded, randomized trial
Aaron P. Kithcart, Margaret Onisko, Wanxue Zou +6
Trials30 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Clinical trials & evidence synthesisCrossref
Safety and efficacy of lacnotuzumab, a colony-stimulating factor 1 antibody for the treatment of tenosynovial giant cell tumors: a randomized phase II trial
Edward Cheng, Ursula Schramm, Alireza Mirzaei +22
Scientific Reports23 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
Efficacy of Kinesio tape for central facial paralysis : A prospective, randomized sham-controlled, single-blinded clinical trial
Xue Li, Jiaojiao Wang, Hua Xiao +4
Medicine9 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{liu2026efficacy,
  title = {{Efficacy and safety of antibody-drug conjugates in pretreated HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials}},
  author = {Fen Liu and Yong Pan and Jinlan Li and Xiaojie Hu and Guisen Yin},
  journal = {Frontiers in pharmacology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655522},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Efficacy and safety of antibody-drug conjugates in pretreated HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials
AU  - Fen Liu
AU  - Yong Pan
AU  - Jinlan Li
AU  - Xiaojie Hu
AU  - Guisen Yin
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in pharmacology
UR  - https://europepmc.org/article/PMC/PMC13655522
SN  - 1663-9812
ER  -

Related

Cite